These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 17314684)
1. Sitaxsentan for the prevention of experimental shunt-induced pulmonary hypertension. Rondelet B; Kerbaul F; Vivian GF; Hubloue I; Huez S; Fesler P; Remmelink M; Brimiouille S; Salmon I; Naeije R Pediatr Res; 2007 Mar; 61(3):284-8. PubMed ID: 17314684 [TBL] [Abstract][Full Text] [Related]
2. Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension. Rondelet B; Dewachter L; Kerbaul F; Dewachter C; Hubloue I; Fesler P; Franck S; Remmelink M; Brimioulle S; Naeije R Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1118-23. PubMed ID: 20693396 [TBL] [Abstract][Full Text] [Related]
3. Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy. Rondelet B; Kerbaul F; Van Beneden R; Motte S; Fesler P; Hubloue I; Remmelink M; Brimioulle S; Salmon I; Ketelslegers JM; Naeije R Circulation; 2004 Oct; 110(15):2220-5. PubMed ID: 15466636 [TBL] [Abstract][Full Text] [Related]
4. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Rondelet B; Kerbaul F; Motte S; van Beneden R; Remmelink M; Brimioulle S; McEntee K; Wauthy P; Salmon I; Ketelslegers JM; Naeije R Circulation; 2003 Mar; 107(9):1329-35. PubMed ID: 12628956 [TBL] [Abstract][Full Text] [Related]
5. Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension. Rondelet B; Kerbaul F; Van Beneden R; Hubloue I; Huez S; Fesler P; Remmelink M; Brimioulle S; Salmon I; Naeije R Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2319-24. PubMed ID: 16024566 [TBL] [Abstract][Full Text] [Related]
6. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets. Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731 [TBL] [Abstract][Full Text] [Related]
7. Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure. Rondelet B; Dewachter C; Kerbaul F; Kang X; Fesler P; Brimioulle S; Naeije R; Dewachter L Eur Heart J; 2012 Apr; 33(8):1017-26. PubMed ID: 21606077 [TBL] [Abstract][Full Text] [Related]
8. A review of STRIDE-2 and STRIDE-2X: the case for selective endothelin receptor blockade. Langleben D; Cacoub P Eur J Clin Invest; 2009 Jun; 39 Suppl 2():27-31. PubMed ID: 19335744 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist. Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286 [TBL] [Abstract][Full Text] [Related]
10. Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension. Horn EM; Widlitz AC; Barst RJ Expert Opin Investig Drugs; 2004 Nov; 13(11):1483-92. PubMed ID: 15500395 [TBL] [Abstract][Full Text] [Related]
11. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Girgis RE; Frost AE; Hill NS; Horn EM; Langleben D; McLaughlin VV; Oudiz RJ; Robbins IM; Seibold JR; Shapiro S; Tapson VF; Barst RJ Ann Rheum Dis; 2007 Nov; 66(11):1467-72. PubMed ID: 17472992 [TBL] [Abstract][Full Text] [Related]
12. Sitaxsentan for treatment of pulmonary hypertension. Wittbrodt ET; Abubakar A Ann Pharmacother; 2007 Jan; 41(1):100-5. PubMed ID: 17164394 [TBL] [Abstract][Full Text] [Related]
13. Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension. Barst RJ Expert Opin Pharmacother; 2007 Jan; 8(1):95-109. PubMed ID: 17163810 [TBL] [Abstract][Full Text] [Related]